Health
FDA approves injectable treatment for HIV patients – OutSourcing-Pharma.com
The agency has given the thumbs up to ViiV’s once-a-month Cabenuva, the first FDA-approved injectable, complete regimen for adults diagnosed with HIV.
The US Food and Drug Administration (FDA) has approved Cabenuva (cabotegravir and rilpivirine) as a complete regimen intended to treat human immunodeficiency virus type 1 (HIV-1) infection in adults. The injectable drug is designed to replace a current antiretroviral regimen in patients who are virologically suppressed on a stable antiretroviral regimen, with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
Cabenuva, a product from…
-
General23 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
Noosa News16 hours agoIs Auckland New Zealand’s New Cultural Capital?
-
General16 hours agoThree maps that show the scale of the NSW flood disaster
-
Business23 hours agoWhere could the RBA interest rate go in the next 12 months?